At Binding Site, we are dedicated to improving patient lives, delivering innovative medical solutions that improve the diagnosis and management of blood cancers and immune system disorders, ensuring we continue to make a difference together.

We recently had the honor of meeting with Yvonne Yaksic, an inspiring 18-year-Myeloma survivor, who has bravely opened up about her own patient journey and what a delay in diagnosis has meant for her.

We urge you to watch Yvonne’s incredible story of resilience. We hope her story will help to inspire you and raise awareness worldwide of the challenges and critical importance of early Multiple Myeloma detection.

Guidelines recommend Freelite tests alongside SPEP and IFE to gain greater diagnostic sensitivity.1-3

Dispenzieri A et al. International Myeloma Working Group Guidelines for serum free light chains in multiple myeloma and other related disorders, Leukemia 2009;23:215
Referenced with permission from The NCCN Clinical Practice Guidelines in Oncology® for Multiple Myeloma 2023. © National Comprehensive Cancer Network, Inc 2022. All rights reserved. Accessed June 2023. To view the most recent and complete version of the guideline, go online to www.nccn.org. NATIONAL COMPREHENSIVE CANCER NETWORK®, NCCN®, NCCN GUIDELINES®, and all other NCCN Content are trademarks owned by the National Comprehensive Cancer Network, Inc.
Keren DF et al. Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies: Guideline From the College of American Pathologists in Collaboration With the American Association for Clinical Chemistry and the American Society for Clinical Pathology. Arch Pathol Lab Med 2021;146:575-90

More Information

Thank you!